# A Study to Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of Age

> **NCT02580201** · PHASE4 · COMPLETED · sponsor: **Fidec Corporation** · enrollment: 154 (actual)

## Conditions studied

- Poliomyelitis

## Interventions

- **BIOLOGICAL:** Oral Polio Vaccine

## Key facts

- **NCT ID:** NCT02580201
- **Lead sponsor:** Fidec Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2016-07
- **Final completion:** 2016-08-11
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2023-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02580201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02580201, "A Study to Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of Age". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02580201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*